1)- Rebekah L Wilson, Cami N Christopher, Eric H Yang, Ana Barac, Scott C Adams, Jessica M Scott, Christina M Dieli-Conwright. Incorporating Exercise Training into Cardio-Oncology Care: Current Evidence and Opportunities: State-of-the-Art Review.JACC. CardioOncology. 2023, 5 (5): 553-569
2)- Cooper Quartermaine, Sanam M Ghazi, Aneeq Yasin, Farrukh T Awan, Michael Fradley, Tracy Wiczer, Sujay Kalathoor, Mussammat Ferdousi, Satyam Krishan, Alma Habib, Adnan Shaaban, Onaopepo Kola-Kehinde, Adam S Kittai, Kerry A Rogers, Michael Grever, Patrick Ruz, Seema Bhat, Tyler Dickerson, John C Byrd, Jennifer Woyach, Daniel Addison. Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia: State-of-the-Art Review.JACC. CardioOncology. 2023, 5 (5): 570-590
3)- Paolo Bima, Pedro Lopez-Ayala, Luca Koechlin, Jasper Boeddinghaus, Thomas Nestelberger, Bernhard Okamura, Tamar S Muench-Gerber, Alessandra Sanzone, Daria Skolozubova, David Djurdjevic, Maria Rubini Gimenez, Karin Wildi, Oscar Miro, Gemma Martínez-Nadal, Francisco J Martin-Sanchez, Michael Christ, Dagmar Keller, Bertil Lindahl, Evangelos Giannitsis, Christian Mueller, . Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins.JACC. CardioOncology. 2023, 5 (5): 591-609
4)- Alexander C Fanaroff, Lova L Sun. High-Sensitivity Troponin in Patients With Cancer: Sensitive But Not Specific.JACC. CardioOncology. 2023, 5 (5): 610-612
5)- Adam J Nelson, Renato D Lopes, Hwanhee Hong, Kaiyuan Hua, Susan Slovin, Sean Tan, Jan Nilsson, Deepak L Bhatt, Shaun G Goodman, Christopher P Evans, Noel W Clarke, Neal D Shore, David Margel, Laurence H Klotz, Bertrand Tombal, Darryl P Leong, John H Alexander, Celestia S Higano. Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer: A Systematic Review.JACC. CardioOncology. 2023, 5 (5): 613-624
7)- Claire Glen, Sarah Adam, Kirsty McDowell, Ashita Waterston, Yun Yi Tan, Mark C Petrie, Caroline J Coats, Ninian N Lang. Cardiotoxicity of BRAF/MEK Inhibitors: A Longitudinal Study Incorporating Contemporary Definitions and Risk Scores.JACC. CardioOncology. 2023, 5 (5): 628-637
8)- Eman R Rashed, Kenneth B Margulies. New Cardiotoxicity Risk Assessment Guidelines: Searching for Validation.JACC. CardioOncology. 2023, 5 (5): 638-640
9)- Moriah P Bellissimo, Justin M Canada, Jennifer H Jordan, Amy C Ladd, Kerryn W Reding, Tonya L Moore, William O Ntim, Emily M Heiston, Peter Brubaker, Shannon L Mihalko, Ralph D'Agostino, Nate O'Connell, Bonnie Ky, Lynne I Wagner, Mary Helen Hackney, Kathryn E Weaver, Glenn J Lesser, Nancy E Avis, Arnethea L Sutton, Alexander R Lucas, R Lee Franco, Bernard F Fuemmeler, Fadi N Salloum, W Gregory Hundley, . Physical Activity During Breast Cancer Therapy Associates With Preserved Exercise Capacity and Cardiac Function (WF97415).JACC. CardioOncology. 2023, 5 (5): 641-652
10)- Melinda R Stolley, David Lewandowski. Exercise as Medicine: Can We Preserve Cardiac Health Through Physical Activity?JACC. CardioOncology. 2023, 5 (5): 653-655
12)- Christopher C Glembotski, Sukriti Bagchi, Erik A Blackwood. ER-Specific Autophagy or ER-Phagy in Cardiac Myocytes Protects the Heart Against Doxorubicin-Induced Cardiotoxicity.JACC. CardioOncology. 2023, 5 (5): 671-673
13)- Takeshi Onoue, Yu Kang, Bénédicte Lefebvre, Amanda M Smith, Srinivas Denduluri, Joseph Carver, Michael G Fradley, Jesse Chittams, Marielle Scherrer-Crosbie. The Association of Metformin With Heart Failure in Patients With Diabetes Mellitus Receiving Anthracycline Chemotherapy.JACC. CardioOncology. 2023, 5 (5): 674-682
14)- Malak El-Rayes, Michelle B Nadler, Husam Abdel-Qadir. Metformin to Prevent Anthracycline Cardiotoxicity?: That Would Be Sweet!JACC. CardioOncology. 2023, 5 (5): 683-685
15)- Zaid H Maayah, Mourad Ferdaoussi, Aristeidis E Boukouris, Shingo Takahara, Subhash K Das, Mostafa Khairy, John R Mackey, Edith Pituskin, Gopinath Sutendra, D Ian Paterson, Jason R B Dyck. Endothelin Receptor Blocker Reverses Breast Cancer-Induced Cardiac Remodeling.JACC. CardioOncology. 2023, 5 (5): 686-700
16)- María Valero-Muñoz, Flora Sam. Endothelin-1: Is it Time to "Biomark" the Cardiac-Tumor-Treatment Nexus in Breast Cancer?JACC. CardioOncology. 2023, 5 (5): 701-703
17)- Suhas Suddala, Nathaniel O'Connell, Ralph D'Agostino, Amy Ladd, Alexander R Lucas, Jennifer H Jordan, Fadi N Salloum, Bonnie Ky, Mary Helen Hackney, W Gregory Hundley. Reduced Thoracic Aortic Distensibility Upon Breast Cancer Diagnosis (WF-97415 and WF-98213).JACC. CardioOncology. 2023, 5 (5): 704-706
18)- Michael G Fradley, Nicholas Wilcox, Irene Frain, Vijay U Rao, Joseph Carver, Avirup Guha, Susan Dent. Developing a Clinical Cardio-Oncology Program and the Building Blocks for Success: How To.JACC. CardioOncology. 2023, 5 (5): 707-710